Adolore Biotherapeutics, Inc. | WebDisclosure

Switch to English

10817	Sociétés
234465	Mots-clés
163321	Articles
125460	Communiqués

Accueil
Sociétés
Adolore Biotherapeutics, Inc.

COMMUNIQUÉ DE PRESSE

publié le 16/05/2024 à 16:00, il y a 2 années 2 mois

Adolore BioTherapeutics Announces Publication Demonstrating Carbonic Anhydrase-8 Gene Therapy (rdHSV-CA8) Decreased Pain-Sensing Neuronal Excitability by Activating Kv7 Voltage-Gated Potassium Channels
Adolore BioTherapeutics announces groundbreaking findings in gene therapy for chronic pain treatment, highlighting the value of non-opioid analgesics and progress with IND-enabling studies

Adolore BioTherapeutics Chronic Pain Gene Therapy Non-opioid Analgesics IND-enabling Studies
BRÈVE

publiée le 04/03/2024 à 16:05, il y a 2 années 5 mois

Adolore BioTherapeutics obtient un brevet américain pour la thérapie génique CA8* dans le traitement de la douleur chronique

Adolore BioTherapeutics Thérapie Génique Traitement De La Douleur Chronique Solutions Sans Opioïdes Délivrance De Brevet
BRÈVE

publiée le 04/03/2024 à 16:05, il y a 2 années 5 mois

Adolore BioTherapeutics Secures U.S. Patent for CA8* Gene Therapy in Chronic Pain Treatment

Adolore BioTherapeutics Gene Therapy Chronic Pain Treatment Opioid-Free Solutions Patent Issuance
COMMUNIQUÉ DE PRESSE

publié le 04/03/2024 à 16:00, il y a 2 années 5 mois

Adolore BioTherapeutics Announces Issuance of First U.S. Patent Covering CA8* Gene Therapies to Treat Chronic Pain
Adolore BioTherapeutics licenses patent and CA8* gene therapy technology from the University of Miami for opioid-free chronic pain treatment. Company progresses toward clinical testing and commercialization

University Of Miami Adolore BioTherapeutics Chronic Pain Opioid-free Gene Therapy
COMMUNIQUÉ DE PRESSE

publié le 30/01/2024 à 16:00, il y a 2 années 6 mois

Adolore BioTherapeutics to Present at the 5th Annual National Institutes of Health (NIH) HEAL Initiative Scientific Meeting
Adolore BioTherapeutics will present at the 5th Annual NIH HEAL Initiative Scientific Meeting regarding the gene therapy program for chronic pain associated with knee osteoarthritis. The program is supported by NIH/NINDS HEAL UH3 Award

Adolore BioTherapeutics Chronic Pain NIH HEAL Initiative Gene Therapy Osteoarthritis
COMMUNIQUÉ DE PRESSE

publié le 05/12/2023 à 16:30, il y a 2 années 8 mois

Adolore BioTherapeutics Presents Promising Preclinical Data Supporting Its Innovative Gene Therapy to Treat Chronic Pain
Adolore BioTherapeutics presented preclinical data supporting its innovative CA8* gene therapy as a long-acting local analgesic for chronic osteoarthritis knee pain management, aiming to replace opioids

Adolore BioTherapeutics CA8* Gene Therapy Chronic Pain Opioid-free Preclinical Data
COMMUNIQUÉ DE PRESSE

publié le 11/10/2023 à 16:00, il y a 2 années 9 mois

Adolore BioTherapeutics to Participate at the Virtual Investor Ask the CEO Conference
COMMUNIQUÉ DE PRESSE

publié le 03/10/2023 à 15:15, il y a 2 années 10 mois

NIN/NINDS HEAL Program Grants Prestigious UH3 Award to the University of Miami, Principal Investigator Roy C. Levitt M.D, to Fund Clinical Development of Adolore BioTherapeutics’ Gene Therapy Program for the Treatment of Chronic Osteoarthritis Knee Pain

Les Echos

Publié le 10/08/2026 à 18:00, il y a 15 heures 9 minutes

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Publié le 10/08/2026 à 18:00, il y a 15 heures 9 minutes

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Publié le 10/08/2026 à 17:45, il y a 15 heures 24 minutes

Weekly share buyback
Publié le 10/08/2026 à 17:45, il y a 15 heures 24 minutes

Déclaration hebdomadaire de rachat d'actions
Publié le 10/08/2026 à 11:53, il y a 21 heures 15 minutes

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 11/08/2026 à 07:00, il y a 2 heures 9 minutes

Alaska Energy Metals Announces Closing of Shares for Debt Settlement
Publié le 11/08/2026 à 00:40, il y a 8 heures 29 minutes

CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Publié le 11/08/2026 à 00:25, il y a 8 heures 44 minutes

Empress Reports 2026 Second Quarter Financial Results
Publié le 10/08/2026 à 23:35, il y a 9 heures 34 minutes

NioCorp Project to Expand Production to 8 Made-in-USA Critical Minerals Over a 40-Year Mine Life with an Estimated $4.1 Billion Pre-Tax NPV8%
Publié le 10/08/2026 à 23:30, il y a 9 heures 39 minutes

Condor and Element79 Agree on Restructured Terms for Lucero Project

Voir tout ACCESSWIRE

EQS Group

Publié le 11/08/2026 à 08:30, il y a 39 minutes

Suspension - Apertura Energy Plc
Publié le 11/08/2026 à 08:30, il y a 39 minutes

Energiekontor AG: Energiekontor optimises wind parks with Smart Windfarm Controller
Publié le 11/08/2026 à 08:05, il y a 1 heure 4 minutes

LX Pantos Strengthens Global ESG Leadership Through Its 2026 Sustainability Report
Publié le 11/08/2026 à 08:00, il y a 1 heure 9 minutes

Cairn Homes Plc: Appointment of Pat Farrell as Independent Non-Executive Director
Publié le 11/08/2026 à 08:00, il y a 1 heure 9 minutes

CANCOM SE continues to significantly strengthen profitability in H1.26